View Full Profile. Learn about our Editorial Policies. Genetic medicines could treat certain diseases, however, the current delivery systems available—viral vectors and lipid nanoparticles (LNPs)—pose ...

Verve Therapeutics said Monday that initial data show that its investigational gene-editing therapy lowered cholesterol ...

Researchers at Oregon State University say they have made a "significant breakthrough" in using nanoparticles to deliver ...

The new gene therapy is delivered to the placenta by a polymer nanoparticle so small it would take roughly 500 of them, side by side, to equal the width of a human hair. The nanoparticle carries ...

Gene therapy for cystic fibrosis is advancing fast. Explore key biotech players, clinical progress, and its potential to ...

The global gene therapy market is projected to grow at a significant CAGR of 20% from 2024 to 2029. This growth is driven by ...

Compared to viral methods commonly used for gene therapy, these DNA-LNPs can carry larger genetic instructions ... Safer non-viral DNA delivery using lipid nanoparticles loaded with endogenous ...

Compared to viral methods commonly used for gene therapy, these DNA-LNPs can carry ... Patel et al, Safer non-viral DNA delivery using lipid nanoparticles loaded with endogenous anti-inflammatory ...

Cancer Gene Therapy Market Breast and Lung Cancer dominate, driven by high incidence and genetic testing integration. US, NY, UNITED ST ...

Marama Labs' CloudSpec speeds up lipid nanoparticle analysis, cutting lab times from hours to seconds for gene therapy and ...

The global lipid nanoparticles market, valued at US$ 820.51 million in 2023, is projected to experience significant growth, with an expected market valuation of US$ 2,387.98 million by 2032. This ...